Trial Profile
Evaluation of Universal Rotavirus Vaccination Program.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Sep 2023
Price :
$35
*
At a glance
- Drugs RIX 4414 (Primary)
- Indications Gastroenteritis; Rotavirus infections
- Focus Therapeutic Use
- 19 Jan 2022 Status changed from recruiting to completed.
- 02 Aug 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 02 Aug 2011 Planned end date changed from 1 Mar 2013 to 1 Feb 2013 as reported by ClinicalTrials.gov.